Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 4, 2021
[Intermolecular interaction-based ubiquitin-proteasome system-targeting drug discovery]Mikihiko Naito, Hirotsugu KomatsuThe Journal of Pharmacy and Pharmacology|November 2, 2005
Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10Tetsuko Fukuda, Masao Hisadome, Hirotsugu KomatsuEuropean Journal of Pharmacology|October 21, 2005
Therapeutic administration of Y-40138, a multiple cytokine modulator, inhibits concanavalin A-induced hepatitis in miceTetsuko Fukuda, Akira Mogami, Masao Hisadome, et al.European Journal of Pharmacology|September 1, 2004
Combination benefit of a pyrimidylpiperazine derivative (Y-40138) and methotrexate in arthritic ratsMasao Hisadome, Tetsuko Fukuda, Kunitomo Adachi, et al.Journal of Pharmacological Sciences|November 30, 2005
Sclerosing effect of OC-108, a novel agent for hemorrhoids, is associated with granulomatous inflammation induced by aluminumTakashi Ono, Kazuko Goto, Shiro Takagi, et al.Journal of Pharmacological Sciences|October 31, 2006
Hemostatic action of OC-108, a novel agent for hemorrhoids, is associated with regional blood flow arrest induced by acute inflammationTakashi Ono, Haruto Nakagawa, Atsushi Fukunari, et al.Life Sciences|April 22, 2006
Y-40138, a multiple cytokine production modulator, protects against D-galactosamine and lipopolysaccharide-induced hepatitisTetsuko Fukuda, Akira Mogami, Hideki Tanaka, et al.Journal of Biomolecular Structure & Dynamics|January 5, 2022
Identification of SARS-CoV-2 main protease inhibitors from FDA-approved drugs by artificial intelligence-supported activity prediction systemHirotsugu Komatsu, Takeshi Tanaka, Zhengmao Ye, et al.The Journal of Veterinary Medical Science|December 11, 2003
Sodium iodoacetate-induced experimental osteoarthritis and associated pain model in ratsKiyoshi Kobayashi, Rei Imaizumi, Hiroshi Sumichika, et al.Chemical & Pharmaceutical Bulletin|August 5, 2005
Biological evaluation of 2-aryl-2-fluoropropionic acids as possible platforms for new medicinal agentsYoshio Takeuchi, Hidehito Fujisawa, Tomoya Fujiwara, et al.Pageof 2